Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Quantum BioPharma's LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or ...

Researchers have identified six key proteins that could be targeted to combat MS progression, and potential drugs that could ...

Scientists hunting for treatments and cures for multiple sclerosis may have found an unlikely ally — the yak. The high-altitude, cold-hardy relative of the cow could be the key to a medical ...

Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on ...

HOUSTON & WALTHAM, Mass.--(BUSINESS WIRE)--Biostate AI, a leading innovator in artificial intelligence for RNA sequencing, today announced a strategic partnership with the Accelerated Cure Project ...

Multiple sclerosis, or MS, is a disease that causes the immune system to attack the protective sheath that covers nerve fibers. Symptoms and severity of the disease vary from person to person. In some ...

Multiple Sclerosis, an autoimmune disease that attacks the central nervous system and can lead to impaired mobility, vision ...

MS relapse risk was low after age 60 whether patients continued or stopped DMTs, but MRI changes were more common than ...